NCT06985004Active, not recruiting
Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire
Predicting Operational Difficulties and Outcomes of Robot-Assisted Radical Prostatectomy (RARP) Based on Preoperative Assessment - Introducing the PIODO (Preoperative Index for Operative Difficulties and Outcomes) Questionnaire
Source: ClinicalTrials.gov · Last updated 22 May 2025
Brief summary (registry, in English)
The goal of this observational study is to learn about the factors that affect the course of robot-assisted radical prostatectomy and have an impact on functional and oncological outcomes in patients undergoing RARP. The main question it aims to answer is: • Can the investigators predict the occurrence of operational difficulties and outcomes of RARP based on preoperative assessment including body habitus and pelvimetry? Participants undergoing RARP will be assessed preoperatively with the use of a PIODO Questionnaire, a structured protocol of preoperative assessment focusing on clinical data and MRI pelvic measurements to evaluate if the investigators can predict the risk of operational difficulties and possible outcomes of RARP. In a 1 year follow-up the investigators will collect data on functional and oncological outcomes.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 288 (actual)
- First submitted
- 9 Apr 2025
- Start date
- 1 Jan 2024
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Pomeranian Medical University Szczecin
- Diseases
- Prostate cancer, Childhood cancers
- NCT number
- NCT06985004
What you commit to
- Study type: Observational
- Participants enrolled: 288
- From 1 Jan 2024 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Neoadjuvant androgen deprivation therapy before RARP.
Other
- Lack of consent for study participation or willingness to comply with all procedures and assessments.
Who the study is looking for
- Patients with prostate cancer undergoing RARP.
Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Urology and Urological Oncology Coordinator of this site? Confirm its status | Szczecin | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.